We observed that the expression of Ki-67 was relatively lower in the HER2-low group compared to the HER2-0 group (P = 0.009, Supplementary Fig. 4a), while there were no significant differences in tumor load parameters such as tumor size and number of metastatic sites between the two groups. Here, ERBB2 is linked to neoplasm.